Dense Tissue Masking Breast Cancer Sparks Screening Debate
As Breast Cancer Awareness Month concludes, doctors are urging women to look beyond standard mammograms, particularly if they have dense breast tissue. KATV reported that medical specialists are emphasizing personal risk factors and breast density year-round, as dense tissue can obscure tumors during routine screenings.
Standard mammograms treat dense tissue and cancer similarly, as both appear white on imaging scans. Dr. Stacy Smith-Foley, a breast imaging specialist at CARTI, likened the detection challenge to “looking for a snowman in a snowstorm.” Because a standard mammogram is frequently insufficient for women with dense tissue, supplemental evaluations such as ultrasounds, contrast-enhanced mammography, or MRIs are often required. While MRIs are typically reserved for patients with a 20% or greater estimated lifetime risk, ultrasound technology serves women at intermediate or average risk.
In Dublin, Evan Holton sought an ultrasound after receiving a clear mammogram in January, despite having no symptoms. That decision revealed a 7cm tumor. Holton subsequently underwent chemotherapy, a mastectomy, lymph-node surgery, and radiotherapy, followed by a second mastectomy in 2020.
On October 13, campaigners including Siobhán, who co-hosted a 2019 public breast-density symposium and established Lobular Ireland, returned to Leinster House. They called for women to be routinely informed of their breast density following mammograms, whether through the national screening program BreastCheck or through private providers. During the Leinster House meeting, Hannah Fox, who lives with stage-four breast cancer, spoke alongside her husband Andy to highlight the human cost of delayed detection related to tissue density.
Screening Protocols and Risk Factors Across Regions
Clinical guidelines establish different baselines for when women should begin monitoring their breast health. CARTI recommends that women at average risk begin routine screenings at age 40, though conversations about family history and personal risk should ideally begin by age 25 with a primary care doctor or gynecologist. Dr. Smith-Foley noted that being a woman is the number one risk factor, famously summarizing that “if you have breasts and you have birthdays, you have risk.”
Conversely, national programs maintain different communication standards regarding tissue composition. BreastCheck does not routinely report breast density to patients, leaving many women unaware that roughly half of women in their 40s possess dense breast tissue. While dense tissue is an independent risk factor associated with an increased likelihood of developing the disease, having dense breasts does not guarantee a cancer diagnosis. Small breasts can be very dense, while larger breasts may not be, and tissue generally becomes less dense with age.
For patients dealing with callback anxiety, statistical context from CARTI shows that out of 1,000 screened women, roughly 10% are called back for additional imaging. Of those callbacks, about a third are determined to be benign, a third are monitored over time, and a third require a biopsy, ultimately resulting in the detection of approximately seven cancers per 1,000 screenings.
Common Questions About Breast Density and Screening
Why does breast density interfere with mammogram results?
Dense breast tissue and cancer tumors both appear white on a standard mammogram, creating a visual overlap that makes abnormalities significantly harder to spot.
What supplemental screenings are available for dense breasts?
Supplemental evaluation options include ultrasound for intermediate-to-average risk patients, contrast-enhanced mammography, and MRIs for patients with a 20% or greater estimated lifetime risk.
Does BreastCheck routinely report density to patients?
No, BreastCheck does not routinely report density, which has led patient advocates and organizations like Lobular Ireland to call for mandatory density disclosures after mammograms.
At what age should women begin discussing breast cancer risk?
Doctors at CARTI recommend that women start discussing family history and personal risk factors with a primary care doctor or gynecologist by the time they reach age 25.
Related reading